Vir Biotechnology VIR Income Statement (2018-2026)

NASDAQ VIR
$11.42 -0.03 (-0.26%)
As of: Sep 4, 2026 · 12:49 PM EDT
Reported Financials

Vir Biotechnology Quarterly Income Statement

Periods 32 quarters
Latest Jun 2026

Vir Biotechnology reported revenue of $238.95M and net income of $80.08M for the quarter ended Jun 2026. This income statement covers 32 quarters of results from Sep 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.)
130.83M131.16M132.35M132.60M133.03M133.24M133.93M134.23M134.50M134.78M135.84M136.59M136.71M136.96M138.06M138.89M139.02M139.47M161.23M169.19M
Revenue & cost
Revenue
103.62M812.75M1,232.46M40.63M374.56M49.41M62.96M3.80M2.64M16.79M56.38M3.08M2.38M12.37M3.03M1.21M0.24M64.07M0.03M238.95M
Gross Profit
95.78M755.87M1,142.31M12.71M352.30M43.41M61.05M3.77M2.60M15.99M56.32M3.02M2.33M11.69M3.03M1.20M238.95M
Operating items
Research & DevelopmentR&D
98.67M128.34M90.23M115.08M114.17M155.17M157.64M168.08M145.03M108.97M100.12M105.11M195.18M106.08M118.64M97.51M151.46M88.35M108.92M135.28M
Selling, General & AdministrativeSG&A
50.50M55.78M38.26M41.59M43.17M38.74M46.78M45.51M40.93M41.22M36.32M30.27M25.74M26.70M23.94M22.28M22.23M23.62M23.34M30.20M
Restructuring CostsRestructuring
5.37M3.37M4.82M-0.05M26.27M12.71M-3.94M-0.01M-0.17M
Other Operating ExpensesOther Opex
7.84M56.88M90.15M27.92M22.25M6.00M1.91M0.02M0.04M0.80M0.06M0.05M0.05M0.68M0.01M-0.01M0.03M
Operating ExpensesOpex
157.00M241.00M218.63M184.59M179.59M199.91M206.33M218.98M189.37M155.80M136.46M161.71M233.68M129.52M142.58M119.63M173.68M111.99M132.26M165.48M
Operating IncomeOp. Inc
-53.38M571.75M1,013.83M-225.22M194.96M-150.50M-143.37M-215.19M-186.73M-139.02M-80.08M-158.63M-231.30M-117.15M-139.55M-118.42M-173.44M-47.92M-132.29M73.47M
EBIT
-53.38M571.75M1,013.83M-225.22M194.96M-150.50M-143.37M-215.19M-186.73M-139.02M-80.08M-158.63M-231.30M-117.15M-139.55M-118.42M-173.44M-47.92M-132.29M73.47M
Non-operating items
Interest & Investment IncomeInt & Inv Inc
0.01M0.17M0.39M2.20M9.33M16.17M21.31M23.02M21.93M20.74M21.28M18.85M17.53M14.15M12.29M10.79M9.36M7.80M7.19M8.97M
Other Non Operating IncomeOther Non Op Inc.
0.06M-0.01M2.73M0.69M27.03M-26.19M-8.02M-0.37M0.88M-1.49M-0.29M-0.54M-0.89M-0.51M-0.07M0.23M-0.23M-0.34M-0.25M-0.45M
Non Operating IncomeNon Op. Inc.
164.15M-25.86M-91.92M-8.50M22.77M-1.14M0.18M17.56M20.11M18.26M15.08M18.74M17.76M12.47M18.60M7.63M10.47M4.86M6.76M6.79M
Net income details
EBT
110.76M545.89M921.91M-233.72M217.73M-151.64M-143.19M-197.62M-166.63M-120.76M-65.00M-139.89M-213.54M-104.67M-120.95M-110.79M-162.97M-43.06M-125.53M80.26M
Tax ProvisionsTaxes
0.33M20.64M403.29M-157.23M42.42M-50.03M-2.23M-2.85M-3.21M-4.78M0.28M-1.51M0.18M-0.09M0.02M0.17M0.17M-0.14M0.17M0.18M
Profit After TaxPAT
110.43M525.25M518.62M-76.49M175.31M-101.60M-140.96M-194.78M-163.41M-115.97M-65.28M-138.38M-213.72M-104.59M-120.97M-110.96M-163.14M-42.92M-125.69M80.08M
Income from Continuing OperationsIncome (Continuing)
110.43M525.25M518.62M-76.49M175.31M-101.60M-140.96M-194.78M-163.41M-115.97M-65.28M-138.38M-213.72M-104.59M-120.97M-110.96M-163.14M-42.92M-125.69M80.08M
Consolidated Net IncomeConsol Net Inc.
110.43M525.25M518.62M-76.49M175.31M-101.60M-140.96M-194.78M-163.41M-115.97M-65.28M-138.38M-213.72M-104.59M-120.97M-110.96M-163.14M-42.92M-125.69M80.08M
Income towards Parent CompanyParent Net Inc
110.43M525.25M518.62M-76.49M175.31M-101.60M-140.96M-194.78M-163.41M-115.97M-65.28M-138.38M-213.72M-104.59M-120.97M-110.96M-163.14M-42.92M-125.69M80.08M
Net Income towards Common StockholdersNet Income
110.43M525.25M518.62M-76.49M175.31M-101.60M-140.90M-194.78M-163.41M-115.97M-65.28M-138.38M-213.72M-104.59M-120.97M-110.96M-163.14M-42.92M-125.69M80.08M
Additional items
EPS (Basic)
0.854.043.93-0.581.32-0.77-1.06-1.45-1.22-0.86-0.48-1.02-1.56-0.77-0.88-0.80-1.17-0.31-0.850.48
EPS (Diluted)
0.823.943.85-0.581.30-0.75-1.06-1.45-1.22-0.86-0.48-1.02-1.56-0.77-0.88-0.80-1.17-0.31-0.850.47
Shares Outstanding
130.67M129.88M132.08M132.45M132.73M132.61M133.55M134.06M134.29M134.13M135.28M136.23M136.65M136.25M137.47M138.45M138.93M138.52M147.36M167.72M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
133.85M133.44M134.54M132.45M134.96M134.81M133.55M134.06M134.29M134.13M135.28M136.23M136.65M136.25M137.47M138.45M138.93M138.52M147.36M168.88M
EBITDA
-53.38M571.75M1,013.83M-225.22M194.96M-150.50M-143.37M-215.19M-186.73M-139.02M-80.08M-158.63M-231.30M-117.15M-139.55M-118.42M-173.44M-47.92M-132.29M73.47M
Tax Rate
0.303.7843.7467.2719.4833.001.561.441.933.96-0.421.08-0.080.08-0.01-0.15-0.100.32-0.140.22